Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 14.

Amann, V C; Ramelyte, E; Thurneysen, S; Pitocco, R; Bentele-Jaberg, N; Goldinger, S M; Dummer, R; Mangana, J (2017). Developments in targeted therapy in melanoma. European Journal of Surgical Oncology, 43(3):581-593.

Amann, V C; Hoffmann, D; Mangana, J; Dummer, R; Goldinger, S M (2017). Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma. Journal of the European Academy of Dermatology and Venerology, 31(10):1638-1640.

Urosevic-Maiwald, M; Mangana, J; Dummer, R (2017). Systemic inflammatory reaction syndrome during combined kinase inhibitor therapy following anti-PD-1 therapy for melanoma. Annals of Oncology, 28(7):1673-1675.

Thurneysen, S; Cheng, P F; Nagel, H W; Kunz, M; Jaberg-Bentele, N; Nägeli, M; Ziegler, M; Guenova, E; Goldinger, S M; Mangana, J; Levesque, M P; Dummer, R (2016). An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel. British Journal of Dermatology, 175(5):966-978.

Jenni, D; Karpova, M B; Mühleisen, B; Mangana, J; Dreier, J; Hafner, J; Dummer, R (2016). A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis. ESMO Open, 1:e000003.

Kunz, M; Urosevic-Maiwald, M; Goldinger, S M; Frauchiger, A L; Dreier, J; Belloni, B; Mangana, J; Jenni, D; Dippel, M; Cozzio, A; Guenova, E; Kamarachev, J; French, L E; Dummer, R (2016). Efficacy and safety of oral alitretinoin in severe oral lichen planus - results of a prospective pilot study. Journal of the European Academy of Dermatology and Venerology, 30(2):293-298.

Frauchiger, A L; Mangana, J; Rechsteiner, M; Moch, H; Seifert, Burkhardt; Braun, R; Dummer, R; Goldinger, S M (2016). Prognostic relevance of LDH and serum S-100 levels in Stage IV melanoma with known BRAF mutation status. British Journal of Dermatology, 174(4):823-830.

Dummer, R; Mangana, J (2013). Carboplatin, paclitaxel and sorafenib in advanced melanoma – what have we learned? Translational Cancer Research, 2:46-47.

Mangana, J; Lévesque, M P; Karpova, M B; Dummer, R (2012). Sorafenib in melanoma. Expert Opinion on Investigational Drugs, 21(4):557-568.

Guggenheim, M; Giovanoli, P; Baumert, B G; Eigentler, T K; Garbe, C; Mangana, J; Dummer, R (2011). Melanoma. In: Dummer, R; Pittelkow, M; Iwatsuki, K; Green, A; Elwan, N M. Skin cancer - a world-wide perspective. Heidelberg, DE: Springer, 307-341.

Zipser, M C; Mangana, J; Oberholzer, P A; French, L E; Dummer, R (2010). Melanoma after laser therapy of pigmented lesions - circumstances and outcome. European Journal of Dermatology, 20(3):334-338.

Mangana, J; Dziunycz, P; Kerl, K; Dummer, R; Cozzio, A (2010). Prevalence of Merkel cell polyomavirus among Swiss Merkel cell carcinoma patients. Dermatology, 221(2):184-188.

Dummer, R; Mangana, J (2009). Long-term pegylated interferon-alpha and its potential in the treatment of melanoma. Biologics: Targets & Therapy, 3:169-182.

Mangana, J; Zipser, M C; Conrad, C; Oberholzer, P A; Cozzio, A; Knuth, A; French, L E; Dummer, R (2008). Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome. European Journal of Dermatology, 18(5):566-570.

This list was generated on Sat Nov 25 01:30:07 2017 CET.